The Efficacy of Local Infiltration Analgesia for Postoperative Pain Management After Total Knee Arthroplasty
NCT ID: NCT04258241
Last Updated: 2020-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2020-03-06
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Consequently, the investigators hypothesized that peripheral nerve blocks (femoral triangle and distal adductor canal blocks) with and without local infiltration analgesia provide similar postoperative pain relieving effects and the ability of early mobilization after total knee arthroplasty.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Hypothesis: peripheral nerve blocks with (LIA+) and without (LIA-) local infiltration analgesia provide similar postoperative pain relieving effects after primary total knee arthroplasty.
Secondary Effects: peripheral nerve blocks with (LIA+) and without (LIA-) local infiltration analgesia provide similar ability to recover after primary total knee arthroplasty.
The objectives:
1. To compare postoperative pain control effects between LIA+ and LIA- groups of patients after primary total knee joint replacement surgery.
2. To assess the ability of early motion and ambulation after total knee joint replacement surgery between the LIA+ and LIA- groups.
3. To estimate opioid consumption and its adverse effects in LIA+ and LIA- groups of patients after primary total knee arthroplasty.
4. To compare the patient's postoperative satisfaction rates in LIA+ and LIA- groups of patients after primary total knee arthroplasty.
Methods:
The prospective, double-blinded study includes American Society of Anesthesiologists (ASA) I-III patients, aged 18-90 years, admitted for primary total knee arthroplasty. Preoperatively patients will be blindly randomized into one of two groups: LIA+ (peripheral nerve blocks with local infiltration analgesia) and LIA- (placebo group, peripheral nerve blocks without local infiltration analgesia). Group assignment will be concealed by opaque envelopes that will be opened only after enrollment. The anesthesiologist performing the block will be aware of the treatment, but the participant and outcomes assessor will be blinded to group assignment.
The anesthesiologist will perform peripheral nerve blocks under the guidance of a linear ultrasound transducer probe. The femoral triangle and distal adductor canal blocks will be performed. The femoral triangle block will be performed at the level where the medial border of the sartorius muscle intersects the medial border of the adductor longus muscle with an injection of 10 ml of 0.125% bupivacaine. A local anesthetic will be injected laterally to the femoral artery. The distal adductor canal block will be performed at the level where the femoral vessels (artery and vein) dive deeper from the sartorius muscle with an injection of 10 ml of 0.125% bupivacaine. A local anesthetic will be injected under the femoral artery. The orthopedic surgeon will perform local infiltration analgesia with 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline in LIA+ group and with 0.3 mg of epinephrine together with 120 ml of normal saline in LIA- group.
At the perioperative period, all patients from both groups will receive a standardized anesthetic and analgesic. Premedication of midazolam 2.5-5 mg and dexamethasone 4 mg will be given to all patients and a slow fluid infusion of crystalloids with 1 g of tranexamic acid and 10 mg of ketamine started once an intravenous cannula will be placed. Spinal anesthesia after identification of the subarachnoid space will be performed with 15 mg of levobupivacaine. After that, peripheral nerve blocks will be performed under the ultrasound guidance. Patients will be sedated with intravenously administered propofol during the surgery. At the end of the operation, local infiltration with or without bupivacaine (depending on the group of patients) will be performed. After the surgery, patients will be transferred to the post-anesthesia care unit (PACU).
At the postoperative period for analgesia NSAIDs will be available to both groups of patients. NSAIDs such as dexketoprofen 50 mg, acetaminophen 1 g - 3 times per day and dexketoprofen/tramadol 25/75 mg will be administered after the surgery. Opioids will also be available to patients as intramuscular boluses of pethidine 50 mg or morphine 10 mg without restriction and administered for moderate or severe pain (VAS pain score of 5 or greater out of 10).
The postoperative pain control efficacy will be assessed at 3, 6, 24 and 48 hours after the surgery using the visual analogue scale (VAS) from 0 to 10 (0 - no pain, 10 - worst imaginable pain) at rest, during active and passive 45-degree knee flexion. All the requirements of additional analgesics and their adverse effects will be recorded.
The extent of motor blockade and the ability of early motion will be evaluated at 3, 6, 24, 48 hours after the surgery. Patients will be asked to flex the foot, flex the knee and to lift the straight leg. The possible motion at 3, 6, 24 and 48 hours postoperatively will be assessed with the Bromage scale grades: Grade I - free movement of legs and feet; Grade II - just able to flex knees with free movement of feet; Grade III - unable to flex knees, but with free movement of feet; Grade IV - unable to move legs or feet.
The patients ability of early ambulation will be evaluated using the Timed Up and Go (TUG) test at 24 and 48 hours after the surgery. To do the TUG test, patients will have to sit down on the bed, get up from the bed, walk 3 meters forward, turn, walk back 3 meters to the bed and sit down. The time taken by a patient to perform this test will be calculated with a chronometer.
After the conversation with each patient and assessment of the postoperative pain control efficacy, the ability of early postoperative motion and ambulation, the rate of patient satisfaction will be evaluated using a 10 point scale from 0 (completely unsatisfied) to 10 (totally satisfied) at 3, 6, 24, 48 hours after the surgery.
According to the study protocol, both groups of patients will be compared in terms of postoperative pain control, opioid consumption, early motion and ambulation ability, the incidence of complications (if any), and patients satisfaction rates over time of clinical recovery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local infiltration analgesia with local anesthetic (LIA+)
Local infiltration analgesia will be performed at the end of the surgery by injection of 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline.
Local infiltration analgesia with local anesthetic
The orthopedic surgeon will perform local infiltration analgesia at the end of the surgery. The knee joint capsule, periarticular and subcutaneous tissues will be infiltrated with 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline.
Needle
18-gauge 40 mm Sterican needle (B. Braun Medical Inc., Melsungen, Germany) will be used to perform local infiltration analgesia.
Solution with local anesthetic
Solution of 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline will be used to perform local infiltration analgesia.
Local infiltration analgesia without local anesthetic (LIA-)
Local infiltration analgesia will be performed at the end of the surgery by injection of 0.3 mg of epinephrine and 120 ml of normal saline.
Local infiltration analgesia without local anesthetic
The orthopedic surgeon will perform local infiltration analgesia at the end of the surgery. The knee joint capsule, periarticular and subcutaneous tissues will be infiltrated with 0.3 mg of epinephrine and 120 ml of normal saline.
Needle
18-gauge 40 mm Sterican needle (B. Braun Medical Inc., Melsungen, Germany) will be used to perform local infiltration analgesia.
Solution without local anesthetic
Solution of 0.3 mg of epinephrine and 120 ml of normal saline will be used to perform local infiltration analgesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local infiltration analgesia with local anesthetic
The orthopedic surgeon will perform local infiltration analgesia at the end of the surgery. The knee joint capsule, periarticular and subcutaneous tissues will be infiltrated with 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline.
Local infiltration analgesia without local anesthetic
The orthopedic surgeon will perform local infiltration analgesia at the end of the surgery. The knee joint capsule, periarticular and subcutaneous tissues will be infiltrated with 0.3 mg of epinephrine and 120 ml of normal saline.
Needle
18-gauge 40 mm Sterican needle (B. Braun Medical Inc., Melsungen, Germany) will be used to perform local infiltration analgesia.
Solution with local anesthetic
Solution of 150 mg of bupivacaine, 0.3 mg of epinephrine and 90 ml of normal saline will be used to perform local infiltration analgesia.
Solution without local anesthetic
Solution of 0.3 mg of epinephrine and 120 ml of normal saline will be used to perform local infiltration analgesia.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 90 years;
* Patients conformed to American Society of Anaesthesiologists (ASA) physical status I-III in preoperative assessment;
* Ability to follow the study protocol.
Exclusion Criteria
* American Society of Anesthesiologists (ASA) physical status classification of IV or higher.
* Coagulopathy.
* Pre-exiting lower extremity neuromuscular disorders.
* Local infection over injection site.
* Allergy or contraindications to the drugs used in the study (local anesthetics, NSAIDs, opioids).
* Chronic opioid use.
* Other type of anesthesia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lithuanian University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inna Jaremko
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arunas Gelmanas, MDPhDAssProf
Role: STUDY_CHAIR
Lithuanian University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lithuanian University of Health Sciences Kauno Klinikos, Department of Anesthesiology
Kaunas, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Arunas Gelmanas, MDPhDAssProf
Role: primary
Inna Jaremko, MD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial. J Arthroplasty. 2018 Jan;33(1):90-96. doi: 10.1016/j.arth.2017.07.024. Epub 2017 Jul 25.
Andersen LO, Kehlet H. Analgesic efficacy of local infiltration analgesia in hip and knee arthroplasty: a systematic review. Br J Anaesth. 2014 Sep;113(3):360-74. doi: 10.1093/bja/aeu155. Epub 2014 Jun 17.
Beswick AD, Dennis J, Gooberman-Hill R, Blom AW, Wylde V. Are perioperative interventions effective in preventing chronic pain after primary total knee replacement? A systematic review. BMJ Open. 2019 Sep 6;9(9):e028093. doi: 10.1136/bmjopen-2018-028093.
Bendtsen TF, Moriggl B, Chan V, Borglum J. The Optimal Analgesic Block for Total Knee Arthroplasty. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):711-719. doi: 10.1097/AAP.0000000000000485.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BEC-MF-36
Identifier Type: -
Identifier Source: org_study_id